Adyar Pm Hospitals And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 30-07-2024
- Paid Up Capital ₹ 4.50 M
as on 30-07-2024
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.88 Cr
as on 30-07-2024
- Revenue -11.26%
(FY 2023)
- Profit -13.11%
(FY 2023)
- Ebitda -15.76%
(FY 2023)
- Net Worth 24.26%
(FY 2023)
- Total Assets 22.65%
(FY 2023)
About Adyar Pm Hospitals And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹2.88 Cr.
Saraswathy Muthusamy, Palanisamy Muthusamy, and Krithika serve as directors at the Company.
- CIN/LLPIN
U85110TN1992PTC022250
- Company No.
022250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Adyar Pm Hospitals And Research Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saraswathy Muthusamy  | Director | 20-Nov-1995 | Current |
| Palanisamy Muthusamy | Director | 20-May-2006 | Current |
| Krithika | Director | 20-May-2006 | Current |
Financial Performance of Adyar Pm Hospitals And Research Centre.
Adyar Pm Hospitals And Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.26% decrease. The company also saw a substantial fall in profitability, with a 13.11% decrease in profit. The company's net worth Soared by an impressive increase of 24.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adyar Pm Hospitals And Research Centre?
In 2021, Adyar Pm Hospitals And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Sep 2022 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 28 Oct 2020 | ₹0.80 M | Open |
State Bank Of India Smecc Creation Date: 22 Feb 2013 | ₹4.30 M | Open |
How Many Employees Work at Adyar Pm Hospitals And Research Centre?
Unlock and access historical data on people associated with Adyar Pm Hospitals And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adyar Pm Hospitals And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adyar Pm Hospitals And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
